However, the presence of these mutations does not equate to therapeutic success.
But testing negative for the three mutations does not mean someone is in the clear, as there are over a thousand BRCA mutations associated with increased cancer risk.
The test is expensive, about $3,000, and a negative test result for known genetic mutations does not necessarily mean a woman's overall breast cancer risk is negligible, experts say.
Obtaining these mutations does not necessarily mean the virus will be transmissible through respiratory droplets between ferrets because the genetic background of each strain is different from the strain used by Herfst et al. (Fig. 1A, blue circle) and the strain used by Imai et al. (Fig. 1J, red circle).
This indicates that introduction of these mutations does not affect the stability of Sso1p and Sso2p.
Furthermore, combining the ΔaceA and ΔsucCD mutations does not reduce the increased intracellular replication of the S. Typhimurium ΔsucCDΔaceA strain to wild-type levels.
Hence, it appears that, the existence of transmitted drug resistance mutations does not affect the co-receptor tropism of the virus.
The frequency of gene conversion of the HYG-CYH2 insert in the SGS1 mutations does not significantly differ from wild type (ACD 97) (Table 2).
Second, if the probability of germline mutations does not increase with male age, then the gametes of older males may be of higher quality, which would lead to preference for older males [8].
The number of genes (and available mutations) does not allow for an extensive study, however even in our limited analysis we have found evidence for genetic interaction with some genes.
If the drugs in use possess a degree of triple cross-resistance (such as imatinib, dasatinib and nilotinib with the T315I mutation), then the presence of other mutations does not really alter the outcome.
